Tidalsense raises $19M for AI-powered COPD diagnostic platform

Source Summary

Tidalsense Ltd. raised $19 million in a funding round for N-Tidal Diagnose, its AI-based diagnostic platform, which can identify chronic obstructive pulmonary disease (COPD) in as little as five minutes.